BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9878012)

  • 1. Peroral famciclovir in the treatment of experimental ultraviolet radiation-induced herpes simplex labialis: A double-blind, dose-ranging, placebo-controlled, multicenter trial.
    Spruance SL; Rowe NH; Raborn GW; Thibodeau EA; D'Ambrosio JA; Bernstein DI
    J Infect Dis; 1999 Feb; 179(2):303-10. PubMed ID: 9878012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose, patient-initiated famciclovir: a randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis.
    Spruance SL; Bodsworth N; Resnick H; Conant M; Oeuvray C; Gao J; Hamed K
    J Am Acad Dermatol; 2006 Jul; 55(1):47-53. PubMed ID: 16781291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination treatment with famciclovir and a topical corticosteroid gel versus famciclovir alone for experimental ultraviolet radiation-induced herpes simplex labialis: a pilot study.
    Spruance SL; McKeough MB
    J Infect Dis; 2000 Jun; 181(6):1906-10. PubMed ID: 10837169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group.
    Sacks SL; Aoki FY; Diaz-Mitoma F; Sellors J; Shafran SD
    JAMA; 1996 Jul; 276(1):44-9. PubMed ID: 8667538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose famciclovir for the treatment of herpes labialis.
    Hull C; Spruance S; Tyring S; Hamed K
    Curr Med Res Opin; 2006 Sep; 22(9):1699-702. PubMed ID: 16968573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group.
    Mertz GJ; Loveless MO; Levin MJ; Kraus SJ; Fowler SL; Goade D; Tyring SK
    Arch Intern Med; 1997 Feb; 157(3):343-9. PubMed ID: 9040303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial.
    Aoki FY; Tyring S; Diaz-Mitoma F; Gross G; Gao J; Hamed K
    Clin Infect Dis; 2006 Jan; 42(1):8-13. PubMed ID: 16323085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group.
    Tyring S; Barbarash RA; Nahlik JE; Cunningham A; Marley J; Heng M; Jones T; Rea T; Boon R; Saltzman R
    Ann Intern Med; 1995 Jul; 123(2):89-96. PubMed ID: 7778840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial.
    Shafran SD; Tyring SK; Ashton R; Decroix J; Forszpaniak C; Wade A; Paulet C; Candaele D
    J Clin Virol; 2004 Apr; 29(4):248-53. PubMed ID: 15018852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinic-initiated, twice-daily oral famciclovir for treatment of recurrent genital herpes: a randomized, double-blind, controlled trial.
    Sacks SL; Aoki FY; Martel AY; Shafran SD; Lassonde M
    Clin Infect Dis; 2005 Oct; 41(8):1097-104. PubMed ID: 16163627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group.
    Spruance SL; Rea TL; Thoming C; Tucker R; Saltzman R; Boon R
    JAMA; 1997 May; 277(17):1374-9. PubMed ID: 9134943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group.
    Diaz-Mitoma F; Sibbald RG; Shafran SD; Boon R; Saltzman RL
    JAMA; 1998 Sep; 280(10):887-92. PubMed ID: 9739972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster.
    Shen MC; Lin HH; Lee SS; Chen YS; Chiang PC; Liu YC
    J Microbiol Immunol Infect; 2004 Apr; 37(2):75-81. PubMed ID: 15181487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-day famciclovir vs. placebo in patient-initiated episodic treatment of recurrent genital herpes in immunocompetent Black patients.
    Leone P; Abudalu M; Mitha E; Gani M; Zhou W; Hamed K
    Curr Med Res Opin; 2010 Mar; 26(3):653-61. PubMed ID: 20070143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Famciclovir for cutaneous herpesvirus infections: an update and review of new single-day dosing indications.
    Chacko M; Weinberg JM
    Cutis; 2007 Jul; 80(1):77-81. PubMed ID: 17725069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and pharmacokinetics of a single 1500-mg dose of famciclovir in adolescents with recurrent herpes labialis.
    Block SL; Yogev R; Waldmeier F; Hamed K
    Pediatr Infect Dis J; 2011 Jun; 30(6):525-8. PubMed ID: 21178655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes.
    Simpson D; Lyseng-Williamson KA
    Drugs; 2006; 66(18):2397-416. PubMed ID: 17181386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral antivirals for the acute treatment of recurrent herpes labialis.
    Jensen LA; Hoehns JD; Squires CL
    Ann Pharmacother; 2004 Apr; 38(4):705-9. PubMed ID: 14966254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Famciclovir suppression of asymptomatic and symptomatic recurrent anogenital herpes simplex virus shedding in women: a randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-center trial.
    Sacks SL
    J Infect Dis; 2004 Apr; 189(8):1341-7. PubMed ID: 15073669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial.
    Chosidow O; Drouault Y; Leconte-Veyriac F; Aymard M; Ortonne JP; Pouget F; Revuz J; Decazes JM; Malkin JE
    Br J Dermatol; 2001 Apr; 144(4):818-24. PubMed ID: 11298543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.